CDC, FDA Recommend Halting Use Of Johnson & Johnson COVID-19 Vaccine Over Blood Clot Concerns

CDC, FDA Recommend Halting Use Of Johnson & Johnson COVID-19 Vaccine Over Blood Clot Concerns

OK! Magazine

Published

As of April 12, the U.S. Centers for Disease Control and Prevention and the Federal Drug Administration are advising the halt of the Johnson & Johnson COVID-19 vaccine.

Full Article